UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
[X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
For the Quarterly Period Ended June 30, 1998
OR
[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Commission File Number 0-26762
PEDIATRIX MEDICAL GROUP, INC.
(Exact name of registrant as specified in its charter)
Florida 65-0271219
(State or other jurisdiction of (I.R.S. Employer Identification No.)
incorporation or organization)
1455 North Park Drive
Ft. Lauderdale, Florida 33326
(Address of principal executive offices)
(Zip Code)
(954) 384-0175
(Registrant's telephone number, including area code)
Not Applicable
(Former name, former address and fiscal year, if changed since last report)
Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months (or such shorter period that the registrant was required
to file such reports), and (2) has been subject to such filing requirements for
the past 90 days. Yes X No
-- --
At August 6,1998, the Registrant had 15,242,831 shares of $0.01 par value common
stock outstanding.
PEDIATRIX MEDICAL GROUP, INC.
INDEX
PART I - FINANCIAL INFORMATION Page
----
ITEM 1. Financial Statements
Condensed Consolidated Balance Sheets as of June 30, 1998 (Unaudited)
and December 31, 1997......................................................................................... 3
Condensed Consolidated Statements of Income for the Three and Six Months Ended
June 30, 1998 and 1997 (Unaudited)............................................................................ 4
Condensed Consolidated Statements of Cash Flows for the Six Months Ended
June 30, 1998 and 1997 (Unaudited)............................................................................ 5
Notes to Condensed Consolidated Financial Statements............................................................ 6
ITEM 2. Management's Discussion and Analysis of
Financial Condition and Results of Operations..................................................... 9
PART II - OTHER INFORMATION..................................................................................... 11
SIGNATURES...................................................................................................... 13
2
PART I - FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS
PEDIATRIX MEDICAL GROUP, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
June 30, 1998 December 31,
(Unaudited) 1997
------------------- -------------------
(in thousands)
ASSETS
Current assets:
Cash and cash equivalents ..................... $ 1,753 $ 18,562
Investments in marketable securities........... -- 27,132
Accounts receivable, net....................... 46,219 34,866
Prepaid expenses............................... 550 873
Other current assets........................... 1,016 586
------------------- -------------------
Total current assets....................... 49,538 82,019
Property and equipment, net......................... 10,644 9,898
Other assets, net................................... 170,624 104,895
------------------- ------------------
Total assets............................... $ 230,806 $ 196,812
=================== ===================
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable and accrued expenses.......... $ 17,083 $ 16,170
Income taxes payable........................... 1,103 1,348
Current portion of note payable................ 200 200
Deferred income taxes.......................... 15,252 10,393
------------------- -------------------
Total current liabilities.................. 33,638 28,111
Line of credit...................................... 10,000 --
Note payable........................................ 2,450 2,550
Deferred income taxes............................... 947 2,442
------------------- -------------------
Total liabilities.......................... 47,035 33,103
Minority interest................................... 4,153 --
Commitments and contingencies
Stockholders' equity:
Preferred stock................................ -- --
Common stock................................... 152 151
Additional paid-in capital..................... 125,162 122,391
Retained earnings.............................. 54,304 41,078
Unrealized gain on investments................. -- 89
------------------- -------------------
Total stockholders' equity................. 179,618 163,709
------------------- -------------------
Total liabilities and stockholders' equity. $ 230,806 $ 196,812
=================== ===================
The accompanying notes are an integral part of
these financial statements
3
PEDIATRIX MEDICAL GROUP, INC.
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(Unaudited)
Three Months Ended Six Months Ended
June 30, June 30,
------------------------------------- -------------------------------------
1998 1997 1998 1997
---------------- --------------- --------------- ----------------
(in thousands, except for per share data)
Net patient service revenue.................. $ 46,144 $ 30,599 $ 83,952 $ 57,612
Operating expenses:
Salaries and benefits..................... 28,584 19,774 52,144 37,383
Supplies & other operating expenses....... 3,393 2,358 6,088 4,460
Depreciation and amortization............. 2,125 1,008 3,813 1,791
---------------- --------------- --------------- ----------------
Total operating expenses ........... 34,102 23,140 62,045 43,634
---------------- --------------- --------------- ----------------
Income from operations ............. 12,042 7,459 21,907 13,978
Investment income............................ 45 563 491 1,298
Interest expense............................. (242) (75) (351) (149)
---------------- --------------- --------------- ----------------
Income before income taxes ......... 11,845 7,947 22,047 15,127
Income tax provision......................... 4,738 3,179 8,821 6,051
---------------- --------------- --------------- ----------------
Net income.............................. $ 7,107 $ 4,768 $ 13,226 $ 9,076
================ =============== =============== ================
Per share data:
Net income per common and
common equivalent share:
Basic .............................. $ .47 $ .32 $ .87 $ .61
================ =============== =============== ================
Diluted ............................ $ .45 $ .30 $ .83 $ .58
================ =============== =============== ================
Weighted average shares used in
computing net income per common and
common equivalent share:
Basic............................... 15,226 15,001 15,192 14,944
================ =============== =============== ================
Diluted............................. 15,900 15,678 15,871 15,611
================ =============== =============== ================
The accompanying notes are an integral part of
these financial statements
4
PEDIATRIX MEDICAL GROUP, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
Six Months Ended
June 30,
-------------------------------------------
1998 1997
---------------- -----------------
(in thousands)
Cash flows provided (used) by operating activities:
Net income $ 13,226 $ 9,076
Adjustments to reconcile net income to net cash provided by
operating activities:
Depreciation and amortization................................. 3,813 1,791
Deferred income taxes......................................... 3,364 2,399
Changes in assets and liabilities:
Accounts receivable...................................... (11,353) (6,332)
Prepaid expenses and other current assets ............... (107) (680)
Income taxes payable..................................... 629 2,146
Other assets............................................. 116 (84)
Accounts payable and accrued expenses.................... (33) 439
---------------- -----------------
Net cash provided by operating activities ........... 9,655 8,755
---------------- -----------------
Cash flows provided (used) by investing activities:
Physician group acquisition payments.............................. (63,891) (30,365)
Purchase of investments........................................... (9,939) (7,074)
Proceeds from sale of investments................................. 36,983 36,567
Purchase of property and equipment................................ (1,401) (1,114)
---------------- -----------------
Net cash used in investing activities................ (38,248) (1,986)
---------------- -----------------
Cash flows provided (used) by financing activities:
Borrowings on line of credit...................................... 10,000 --
Payments on note payable.......................................... (100) (100)
Proceeds from issuance of common stock............................ 1,884 2,265
---------------- -----------------
Net cash provided by financing activities ........... 11,784 2,165
---------------- -----------------
Net (decrease) increase in cash and cash equivalents .................. (16,809) 8,934
Cash and cash equivalents at beginning of period ...................... 18,562 18,435
---------------- -----------------
Cash and cash equivalents at end of period.............................. $ 1,753 $ 27,369
================ =================
The accompanying notes are an integral part of
these financial statements
5
PEDIATRIX MEDICAL GROUP, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
June 30, 1998
(Unaudited)
1. Basis of Presentation:
The accompanying unaudited condensed consolidated financial statements
of Pediatrix Medical Group, Inc. (the "Company" or "Pediatrix")
presented herein do not include all disclosures required by generally
accepted accounting principles for complete financial statements. In
the opinion of management, these financial statements include all
adjustments, consisting only of normal recurring adjustments, necessary
for a fair presentation of the results of interim periods.
The results of operations for the three and six months ended June 30,
1998 are not necessarily indicative of the results of operations to be
expected for the year ended December 31, 1998. The interim condensed
consolidated financial statements should be read in conjunction with
the consolidated financial statements and footnotes thereto included in
the Company's Annual Report on Form 10-K filed with the Securities and
Exchange Commission on March 31, 1998.
2. Business Acquisitions:
During the first six months of 1998, the Company completed the
acquisition of 10 physician group practices. Total consideration for
these acquisitions approximated $62 million in cash and 4,136,934
shares of stock in a subsidiary of the Company.
The Company has accounted for the acquisitions using the purchase
method of accounting and the excess of cost over fair value of net
assets acquired is being amortized on a straight-line basis over 25
years. The results of operations of the acquired practices have been
included in the consolidated financial statements from the dates of
acquisition.
The following unaudited pro forma information combines the consolidated
results of operations of the Company and the physician group practices
acquired during 1997 and 1998 as if the acquisitions had occurred on
January 1, 1997:
Six Months Ended
June 30,
----------------------------------------
1998 1997
---------------- ----------------
(in thousands, except for per share
data)
Net patient service revenue $ 88,698 $ 76,347
Net income 13,436 9,797
Net income per share:
Basic .88 .66
Diluted .85 .63
The pro forma results do not necessarily represent results which would
have occurred if the acquisitions had taken place at the beginning of
the period, nor are they indicative of the results of future combined
operations.
6
PEDIATRIX MEDICAL GROUP, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (Continued)
(Unaudited)
3. Accounts Payable and Accrued Expenses:
Accounts payable and accrued expenses consists of the following:
June 30, December 31,
1998 1997
-------------------- --------------------
(in thousands)
Accounts payable............................ $ 2,624 $ 2,988
Accrued salaries and bonuses................ 5,195 5,340
Accrued payroll taxes and benefits.......... 3,308 3,013
Accrued professional liability coverage..... 4,298 3,747
Other accrued expenses...................... 1,658 1,082
-------------------- ---------------------
$ 17,083 $ 16,170
==================== =====================
4. Net Income Per Share:
Basic net income per share is calculated by dividing net income by the
weighted average number of common shares outstanding during the period.
Diluted net income per share is calculated by dividing net income by
the weighted average number of common and potential common shares
outstanding during the period. Potential common shares consist of the
dilutive effect of outstanding options calculated using the treasury
stock method.
5. Accounting Pronouncements Recently Issued:
During 1998, the Company adopted the provisions of SFAS No. 130,
"Reporting Comprehensive Income," which requires that all items
recognized under accounting standards as components of comprehensive
income be reported in the financial statements. The Company's
comprehensive income was as follows:
Three Months Ended Six Months Ended
June 30, June 30,
---------------------------- -----------------------------
1998 1997 1998 1997
------------ ------------ ------------- ------------
(in thousands)
Net income.......................................... $ 7,107 $ 4,768 $ 13,226 $ 9,076
Other comprehensive income (loss) net of tax:
Unrealized holding losses arising during the
period.................................. -- (1) -- (1)
Reclassification adjustment for (gains) losses
included in net income -- 39 (89) 30
------------ ------------ ------------- -------------
Net (gains) losses recognized in other
comprehensive income........................ -- 38 (89) 29
------------ ------------ ------------- -------------
Comprehensive income................................ $ 7,107 $ 4,806 $ 13,137 $ 9,105
============ ============ ============= ============
7
PEDIATRIX MEDICAL GROUP, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (Continued)
(Unaudited)
6. Contingencies:
During the ordinary course of business, the Company has become a party
to pending and threatened legal actions and proceedings, most of which
involve claims of medical malpractice and are generally covered by
insurance. These lawsuits are not expected to result in judgments which
would exceed professional liability insurance coverage, and, therefore
will not have a material impact on the Company's consolidated results
of operations, financial position or liquidity, notwithstanding any
possible insurance recovery.
8
ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
RESULTS OF OPERATIONS
Results of Operations
Three Months Ended June 30, 1998 as Compared to Three Months Ended
June 30, 1997
The Company reported net patient service revenue of $46.1 million for
the three months ended June 30, 1998, as compared with $30.6 million for the
same period in 1997, a growth rate of 50.8%. Of this $15.5 million increase,
$14.4 million, or 92.9% was attributable to new units, including units at which
the Company provides services as a result of acquisitions. Same unit patient
service revenue, exclusive of administrative fees, increased $1.5 million, or
5.6%, for the three months ended June 30, 1998. Same units are those units at
which the Company provided services for the entire period for which the
percentage is calculated and the entire comparable period.
Salaries and benefits increased $8.8 million, or 44.6% to $28.6 million
for the three months ended June 30, 1998, as compared with $19.8 million for the
same period in 1997. Of this $8.8 million increase, $6.5 million, or 73.7%, was
attributable to hiring new physicians, primarily to support new unit growth, and
the remaining $2.3 million was primarily attributable to increased support staff
and resources added in the areas of nursing, management and billing and
reimbursement. Supplies and other operating expenses increased $1.0 million, or
43.9% to $3.4 million for the three months ended June 30, 1998, as compared with
$2.4 million for the same period in 1997, primarily as a result of new units.
Depreciation and amortization expense increased by $1.1 million, or 110.8% to
$2.1 million for the three months ended June 30, 1998, as compared with $1.0
million for the same period in 1997, primarily as a result of amortization of
goodwill in connection with acquisitions.
Income from operations increased approximately $4.6 million, or 61.4%,
to $12.0 million for the three months ended June 30, 1998, as compared with $7.5
million for the same period in 1997. The increase in income from operations was
primarily due to increased volume, principally from acquisitions.
The Company earned investment income of approximately $45,000 for the
three months ended June 30, 1998, as compared with approximately $563,000 for
the same period in 1997. The decrease in investment income resulted primarily
from the use of funds in connection with acquisitions.
The effective income tax rate was approximately 40.0% for the three
month periods ended June 30, 1998 and 1997.
Net income increased 49.1% to $7.1 million for the three months ended
June 30, 1998, as compared with $4.8 million for the same period in 1997. Net
income as a percentage of net patient service revenue decreased to 15.4% for the
three months ended June 30, 1998, compared to 15.6% for the same period in 1997
primarily as a result of a decrease in investment income.
Six Months Ended June 30, 1998 as Compared to Six Months Ended
June 30, 1997
The Company reported net patient service revenue of $84.0 million for
the six months ended June 30, 1998, as compared with $57.6 million for the same
period in 1997, a growth rate of 45.7%. Of this $26.4 million increase, $24.8
million, or 93.9% was attributable to new units at which the Company provides
services as a result of acquisitions. Same unit patient service revenue,
exclusive of administrative fees, increased $2.3 million, or 5.2%, for the six
months ended June 30, 1998. Same units are those units at which the Company
provided services for the entire period for which the percentage is calculated
and the entire comparable period.
Salaries and benefits increased $14.8 million, or 39.5% to $52.1
million for the six months ended June 30, 1998, as compared with $37.4 million
for the same period in 1997. Of this $14.8 million increase, $10.9 million, or
73.6%, was attributable to hiring new physicians, primarily to support new unit
9
growth, and the remaining $3.9 million was primarily attributable to increased
support staff and resources added in the areas of nursing, management and
billing and reimbursement. Supplies and other operating expenses increased $1.6
million, or 36.5% to $6.1 million for the six months ended June 30, 1998, as
compared with $4.5 million for the same period in 1997, primarily as a result of
new units. Depreciation and amortization expense increased by $2.0 million, or
112.9% to $3.8 million for the six months ended June 30, 1998, as compared with
$1.8 million for the same period in 1997, primarily as a result of amortization
of goodwill in connection with acquisitions.
Income from operations increased approximately $8.0 million, or 56.7%,
to $22.0 million for the six months ended June 30, 1998, as compared with $14.0
million for the same period in 1997. The increase in income from operations was
primarily due to increased volume, principally from acquisitions.
The Company earned investment income of approximately $491,000 for the
six months ended June 30, 1998, as compared with $1.3 million for the same
period in 1997. The decrease in investment income resulted primarily from the
use of funds in connection with acquisitions.
The effective income tax rate was approximately 40.0% for the six month
periods ended June 30, 1998 and 1997.
Net income increased 45.7% to $13.2 million for the six months ended
June 30, 1998, as compared with $9.1 million for the same period in 1997. Net
income as a percentage of net patient service revenue was 15.8% for the six
month periods ended June 30, 1998 and 1997.
Liquidity and Capital Resources
As of June 30, 1998, the Company had working capital of approximately
$15.9 million, a decrease of $38.0 million from the working capital of $53.9
million available at December 31, 1997. The decrease is principally a result of
funds utilized for acquisitions during the first six months of 1998, offset by
cash generated from operations.
The Company anticipates that funds generated from operations together
with cash and funds available under its credit facility, will be sufficient to
meet its working capital requirements and finance any required capital
expenditures for at least the next twelve months.
10
PART II - OTHER INFORMATION
Item 1. Legal Proceedings
------------------
During the ordinary course of business, the Company has become
a party to pending and threatened legal actions and proceedings, most
of which involve claims of medical malpractice and are generally
covered by insurance. These lawsuits are not expected to result in
judgments which would exceed professional liability insurance coverage,
and, therefore will not have a material impact on the Company's
consolidated results of operations, financial position or liquidity,
notwithstanding any possible insurance recovery.
During 1998, the Internal Revenue Service concluded its
examination of the Company for the tax years ended December 31, 1992,
1993 and 1994. The resolution of the examination did not have a
material effect on the Company's consolidated financial position or
results of operations.
Item 2. Changes in Securities
---------------------
Not applicable.
Item 3. Defaults Upon Senior Securities
-------------------------------
Not applicable.
Item 4. Submission of Matters to a Vote of Security-Holders
---------------------------------------------------
(a) The Company's Annual Meeting of Shareholders was held on May 14,
1998.
(b) Not required.
(c) The matters voted on at the Annual Meeting of Shareholders and
the tabulation of votes on such matters are as follows:
1. Election of Directors:
Against or
Name For Withheld Abstained Broker Non-Vote
- ------------------------------- ----------- -------- --------- ---------------
Roger J. Medel, M.D., M.B.A. 12,666,503 63,228 0 0
E. Roe Stamps, IV 12,712,313 17,418 0 0
Bruce R. Evans 12,712,343 17,388 0 0
Michael B. Fernandez 12,666,383 63,348 0 0
Albert H. Nahmad 12,712,283 17,448 0 0
M. Douglas Cunningham, M.D. 12,666,423 63,308 0 0
Cesar L. Alvarez 12,420,886 308,845 0 0
11
Item 5. Other Information
-----------------
Not applicable.
Item 6. Exhibits and Reports on Form 8-K
--------------------------------
(a) Exhibits
10.33 Amendment No. 3 to Amended and Restated Credit
Agreement, dated March 10, 1998 between Pediatrix,
certain PA Contractors, BankBoston and SunTrust Bank
10.34 Amendment No. 4 to Amended and Restated Credit
Agreement, dated June 24, 1998 between Pediatrix,
certain PA Contractors, BankBoston and SunTrust Bank
10.35 Pediatrix Executive Non-Qualified Deferred
Compensation Plan, dated October 13,1997
11.1 Statement Re: Computation of Per Share Earnings
27.1 Financial Data Schedule
(b) Reports on Form 8-K
None.
12
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
PEDIATRIX MEDICAL GROUP, INC.
Date: August 12, 1998 By: /s/ Roger J. Medel
-------------------
Roger J. Medel, President and
Chief Executive Officer
(Principal Executive Officer)
Date: August 12, 1998 By: /s/ Karl B. Wagner
-------------------
Karl B. Wagner, Chief Financial
Officer (Principal Financial and
Accounting Officer)
13
AMENDMENT NO. 3
TO AMENDED AND RESTATED CREDIT AGREEMENT
Dated as of March 10, 1998
This Agreement, dated as of March 10, 1998, is among Pediatrix Medical
Group, Inc., a Florida corporation, the Related Entities of Pediatrix Medical
Group, Inc. from time to time party hereto, the Lenders from time to time party
hereto including SunTrust Bank/South Florida, National Association (the "Prior
Lender") as Lender under the Revolving Loan, and BankBoston, N.A. (formerly
known as The First National Bank of Boston), both in its capacity as a Lender
under the Revolving Loan and the Mortgage Loan and in its capacity as agent for
itself and the other Lenders (collectively the foregoing parties, the "Credit
Parties"). The parties agree as follows:
1. REFERENCE TO CREDIT AGREEMENT; DEFINITIONS. Reference is made to the First
Amended and Restated Credit Agreement dated as of June 27, 1996 (the "Credit
Agreement"), as amended and in effect from time to time, among the Credit
Parties hereto. Terms defined in the Credit Agreement and not otherwise defined
herein are used herein with the meanings so defined.
2. AMENDMENT TO CREDIT AGREEMENT. Subject to all the terms and conditions
hereof, the Credit Agreement is hereby amended as follows, effective as of the
later of March 10, 1998 and the date each of the conditions in Section 4 hereof
is satisfied or waived:
2.1. Amendment of Section 2.1.3. Section 2.1.3. of the Credit
Agreement is hereby amended and restated to read as follows:
" 2.1.3. Borrowing Requests. Any Borrower may from time to
time request a loan under Section 2.1.1 by providing to the
Agent a notice (which may be given by a telephone call
received by a Lending Officer if promptly confirmed in
writing). Such notice must be not later than noon (Boston
time) on the requested Closing Date, (which shall be the third
Banking Day prior to the requested Closing Date for such loan
if any portion of such loan will be subject to a Eurodollar
Pricing Option on the requested Closing Date). If such notice
requested that a loan, or any portion thereof, be made subject
to a Eurodollar Pricing Option, and the Agent shall have
notified the Borrower pursuant to Section 3.2.2 that such
election did not become effective, the notice shall be deemed
to have been made for a loan at the Base Rate. The notice must
specify (a) the amount of the requested loan (which shall be
not less than $50,000 and an integral multiple of $10,000),
(b) the requested Closing Date therefor (which shall be a
Banking Day) and (c) the portion of the requested loan that is
to be used for purposes other than Permitted Acquisitions.
Upon receipt of such notice, the Agent will promptly inform
each other Lender (by telephone or otherwise). Each such loan
will be made at the Boston Office by depositing the amount
thereof to the general account of such Borrower with the
Agent. In connection with each such loan, such Borrower shall
furnish to the Agent a certificate in substantially the form
of Exhibit 5.4.1."
2.2. Amendment of Section 4.1.4. Section 4.1.4. of the Credit
Agreement is hereby amended and restated to read as follows:
"4.1.4. Reborrowing; Application of Payments. The amounts of
the Revolving Loan prepaid pursuant to Section 4.1.3 may be
reborrowed from time to time prior to the Final Maturity Date
in accordance with Section 2.1. The amount of the Revolving
Loan prepaid pursuant to Section 4.1.1 may not be reborrowed.
All payments of principal hereunder shall be made to the Agent
for the account of the Lenders and shall be applied first to
the portion of the Revolving Loan not then subject to
Eurodollar Pricing Option then the balance of any such payment
shall be applied to a portion of the Revolving Loan then
subject to the Eurodollar Pricing Options, in the
chronological order of the respective maturities, thereof,
together with any payment required by Section 3.4."
2.3. Amendment of Section 6.9.5. Section 6.9.5. of the Credit
Agreement is hereby amended and restated to read as follows:
"6.9.5. Loans to employees not to exceed a principal amount of
$1,000,000 in the aggregate at any one time outstanding
provided that loans may be made to selling physicians as part
of the consideration in a Permitted Acquisition in an amount
not to exceed $3,500,000."
2.4. Amendment of Section 7.1.3. Section 7.1.3. of the Credit
Agreement is hereby amended and restated to read as follows:
"7.1.3. Capitalization. Other than up to 30% in the aggregate
of the outstanding capital stock of Obstetrix Medical Group,
Inc. issued to selling physicians or their advisors as part of
the consideration in a Permitted Acquisition or issued to
physicians who are employed by or otherwise affiliated with
the Borrowers, no options, warrants, conversion rights,
preemptive rights or other statutory or contractual rights to
purchase shares of capital stock or other securities of any
Borrower, other than the Company, now exist, nor has any
Borrower, other than the Company, authorized any such right,
nor is any Borrower, other than the Company, obligated in any
other manner to issue shares of its capital stock or other
securities."
3. NO DEFAULT. In order to induce the Lenders to enter into this Amendment and
to continue to extend credit to the Borrowers under the Credit Agreement as
amended hereby, each of the Borrowers represents and warrants that, after giving
effect to this Amendment, no Default under the Credit Agreement as amended
hereby exists.
2
4. CONDITIONS. On or prior to the Amendment Date:
4.1. Each Borrower shall have duly executed and delivered to the
Agent a Revolving Note for each Lender, dated as of June 27,
1996;
4.2. The Company shall have delivered to the Agent an Officers
Certificate in the form of Exhibit A to this Agreement
certifying that the representations and warranties contained
in Section 7 of the Credit Agreement are true and correct on
and as of the Amendment Date with the same force and effect as
though made on and as of such date (except as to any
representation or warranty which refers to a specific earlier
date); that the Borrowers are in compliance with the covenants
contained in Section 6 of the Credit Agreement and no Default
shall exist on the Amendment Date prior to or immediately
after giving effect to the requested extension of credit; and
that no Material Adverse Change has occurred since December
31, 1995;
4.3. The making of the requested Amendment and extension of credit
shall not (a) subject any Lender to any penalty or special tax
(other than a Tax for which the Borrowers are required to
reimburse the Lenders under Section 3.5 of the Credit
Agreement), (b) be prohibited by any Legal Requirement or (c)
violate any credit restraint program of the executive branch
of the government of the United States of America, the Board
of Governors of the Federal Reserve System or any other
governmental or administrative agency so long as any Lender
reasonably believes that compliance is in the best interests
of the Lender.
4.4. This Amendment. the Credit Agreement and each other Credit
Document and the transactions contemplated hereby and thereby
shall have been authorized by all necessary corporate or other
proceedings of the Borrowers. All necessary consents,
approvals and authorizations of any governmental or
administrative agency or any other Person of any of the
transactions contemplated hereby or by any other Credit
Document shall have been obtained and shall be in full force
and effect;
5. MISCELLANEOUS. Except to the extent specifically amended hereby, the
provisions of the Credit Agreement shall remain unmodified, and the Credit
Agreement as amended hereby is confirmed as being in full force and effect. This
Amendment may be executed in any number of counterparts which together shall
constitute one instrument, shall be governed by and construed in accordance with
the laws of The Commonwealth of Massachusetts (other than conflict of laws
rules), and shall bind and inure to the benefit of the parties hereto and their
respective successors and assigns, including as such successors and assigns all
holders of Credit Obligations.
3
IN WITNESS WHEREOF, the parties have caused this Amendment to be
executed and delivered by their duly authorized officers as of the date first
above written.
PEDIATRIX MEDICAL GROUP, INC.
By: /s/ Lawrence M. Mullen
----------------------
Lawrence M. Mullen, Vice President and
Chief Financial Officer
PEDIATRIX MEDICAL GROUP OF
FLORIDA, INC.
By: /s/ Lawrence M. Mullen
-----------------------
Lawrence M. Mullen, Treasurer
PEDIATRIX MEDICAL GROUP, P.C. (WV)
By: /s/ Lawrence M. Mullen
-----------------------
Lawrence M. Mullen, Treasurer
PEDIATRIX MEDICAL GROUP, P.C. (VA)
By: /s/ Lawrence M. Mullen
-----------------------
Lawrence M. Mullen, Treasurer
PEDIATRIX MEDICAL GROUP, S.P. (PR)
By: /s/ Lawrence M. Mullen
-----------------------
Lawrence M. Mullen, Attorney-in-Fact
PEDIATRIX MEDICAL GROUP, P.A. (NJ)
By: /s/ Lawrence M. Mullen
-----------------------
Lawrence M. Mullen, Treasurer
PEDIATRIX MEDICAL GROUP OF
KANSAS, P.A.
By: /s/ Lawrence M. Mullen
-----------------------
Lawrence M. Mullen, Attorney-in-Fact
PEDIATRIX MEDICAL GROUP
NEONATOLOGY
AND PEDIATRIC INTENSIVE CARE
SPECIALISTS OF NEW YORK, P.C.
By: /s/ Lawrence M. Mullen
-----------------------
Lawrence M. Mullen, Attorney-in-Fact
PEDIATRIX MEDICAL GROUP OF
CALIFORNIA, P.C.
By: /s/ Lawrence M. Mullen
-----------------------
Lawrence M. Mullen, Attorney-in-Fact
PEDIATRIX MEDICAL GROUP OF
ILLINOIS, P.C.
By: /s/ Brian D. Udell, M.D.
-------------------------
Brian D. Udell, M.D., President
PEDIATRIX MEDICAL GROUP OF
MICHIGAN, P.C.
By: /s/ Lawrence M. Mullen
-----------------------
Lawrence M. Mullen, Treasurer
PEDIATRIX MEDICAL GROUP OF
PENNSYLVANIA, P.C.
By: /s/ Brian D. Udell
-------------------
Brian D. Udell, M.D., President
PEDIATRIX MEDICAL GROUP OF
TEXAS, P.A.
By: /s/ Lawrence M. Mullen
-----------------------
Lawrence M. Mullen, Attorney-in-Fact
PEDIATRIX MEDICAL GROUP OF
OHIO, CORP.
By: /s/ Lawrence M. Mullen
-----------------------
Lawrence M. Mullen, Treasurer
NEONATAL SPECIALISTS, LTD. (AZ)
By: /s/ Lawrence M. Mullen
-----------------------
Lawrence M. Mullen, Treasurer
PEDIATRIX MEDICAL GROUP OF
COLORADO, P.C.
By: /s/ Lawrence M. Mullen
-----------------------
Lawrence M. Mullen, Attorney-in-Fact
ST. JOSEPH NEONATOLOGY
CONSULTANTS, P.A.
By: /s/ Lawrence M. Mullen
-----------------------
Lawrence M. Mullen, Attorney-in-Fact
PERNOLL MEDICAL GROUP OF
NEVADA, LTD. D/B/A PEDIATRIX
MEDICAL GROUP OF NEVADA
By: /s/ Lawrence M. Mullen
-----------------------
Lawrence M. Mullen, Attorney-in-Fact
PEDIATRIX MEDICAL GROUP OF
SOUTH CAROLINA, P.A.
By: /s/ Lawrence M. Mullen
-----------------------
Lawrence M. Mullen, Treasurer
FLORIDA REGIONAL NEONATAL
ASSOCIATES, P.A.
By: /s/ Lawrence M. Mullen
-----------------------
Lawrence M. Mullen, Treasurer
PEDIATRIX MEDICAL GROUP, INC.
(Utah)
By: /s/ Lawrence M. Mullen
-----------------------
Lawrence M. Mullen, Treasurer
PEDIATRIX MEDICAL GROUP OF
NEW MEXICO, P.C.
By: /s/ Lawrence M. Mullen
-----------------------
Lawrence M. Mullen, Treasurer
PEDIATRIX MEDICAL GROUP OF
WASHINGTON, INC., P.C.
By: /s/ Lawrence M. Mullen
-----------------------
Lawrence M. Mullen, Treasurer
PEDIATRIX MEDICAL GROUP OF
INDIANA, P.C.
By: /s/ Brian D. Udell,
--------------------
Brian D. Udell, M.D., President
FORT WORTH NEONATAL
ASSOCIATES, P.A.
By: /s/ Lawrence M. Mullen
-----------------------
Lawrence M. Mullen, Attorney-in-Fact
PMG ACQUISITION CORP.
By: /s/ Lawrence M. Mullen
-----------------------
Lawrence M. Mullen, Treasurer
PEDIATRIX MEDICAL GROUP OF
PUERTO RICO, P.S.C.
By: /s/ Lawrence M. Mullen
-----------------------
Lawrence M. Mullen, Attorney-in-Fact
OBSTETRIX MEDICAL GROUP, INC.
By: /s/ Lawrence M. Mullen
-----------------------
Lawrence M. Mullen, Treasurer
OBSTETRIX MEDICAL GROUP OF
FLORIDA, INC.
By: /s/ Lawrence M. Mullen
-----------------------
Lawrence M. Mullen, Treasurer
BANKBOSTON, N.A.
(formerly known as The First National Bank
of Boston)
By: /s/ Gregory G. O'Brien
-----------------------
Gregory G. O'Brien, Managing Director
BankBoston, N.A.
New England Corporate Banking
100 Federal Street
Boston, Massachusetts 02110
Telecopy: (617) 434-1279
Telex: 940581
SUNTRUST BANK/CENTRAL FLORIDA,
NATIONAL ASSOCIATION
By: /s/ Ronald K. Rueve
--------------------
Ronald K. Rueve, Vice President
SunTrust Bank/Central Florida, National Association
Health Care Banking Group
Mail Code: 0-1101
200 S. Orange Avenue
Orlando, Florida 32801
Telecopy (407) 237-5489
AMENDMENT NO. 4
TO AMENDED AND RESTATED CREDIT AGREEMENT
Dated as of June 24, 1998
This Agreement, dated as of June 24, 1998, is among Pediatrix Medical
Group, Inc., a Florida corporation, the Related Entities of Pediatrix Medical
Group, Inc. from time to time party hereto, the Lenders from time to time party
hereto including SunTrust Bank/South Florida, National Association (the "Prior
Lender") as Lender under the Revolving Loan, and BankBoston, N.A. (formerly
known as The First National Bank of Boston), both in its capacity as a Lender
under the Revolving Loan and the Mortgage Loan and in its capacity as agent for
itself and the other Lenders (collectively the foregoing parties, the "Credit
Parties"). The parties agree as follows:
1. REFERENCE TO CREDIT AGREEMENT; DEFINITIONS. Reference is made to the First
Amended and Restated Credit Agreement dated as of June 27, 1996 (the "Credit
Agreement"), as amended and in effect from time to time, among the Credit
Parties hereto. Terms defined in the Credit Agreement and not otherwise defined
herein are used herein with the meanings so defined.
2. AMENDMENT TO CREDIT AGREEMENT. Subject to all the terms and conditions
hereof, effective as of the date hereof, the Credit Agreement is amended as
follows:
2.1. Amendment of Section 1.97. Section 1.97 of the Credit
Agreement is hereby amended to read in its entirety as
follows:
"1.97. "Operating Cash Flow" means, for any period, the
total of:
(a) Consolidated EBITDA;
minus (b) Capital Expenditures (other than Capital
Expenditures of up to $10,000,000 spent on
the Borrowers' new corporate headquarters
building to be located in the Sawgrass
International Corporate Park in Sunrise
Florida);
minus (c) taxes based upon or measured by net
income that are actually paid in cash
during such period."
2.2. Amendment of Section 2.3.1. Section 2.3.1 of the Credit
Agreement is hereby amended to read in its entirety as
follows:
"2.3.1 The Loans. Subject to Section 2.3.2, the Borrowers will
apply the proceeds of the Loans (a) to fund Permitted
Acquisitions and (b) for working capital (including
contruction and related costs for a new corporate headquarters
provided, however, proceeds from the Revolving Loan used for
purposes other than funding Permitted Acquisitions or
construction and related costs for a new corporate
headquarters may never exceed 15% of the Maximum Amount of
Revolving Credit, minus the Specified Insurance Reserve
Amount."
2.3. Amendment of Section 6.11. Section 6.11 of the Credit
Agreement is hereby amended to read in its entirety as
follows:
"6.11. Capital Expenditures. None of the Borrowers will make
Capital Expenditures exceeding $3,000,000 in the aggregate in
any fiscal year; provided, however, that in addition to the
foregoing amount, the Borrowers may spend up to $10,000,000 on
their new corporate headquarters building to be located in the
Sawgrass International Corporate Park in Sunrise Florida."
2.4. Amendment of Section 7.1.3. Section 7.1.3 of the Credit
Agreement is hereby amended to read in its entirety as
follows:
"7.1.3. Capitalization. Other than up to 30% in the aggregate
of the outstanding capital stock of Obstetrix Medical Group,
Inc. issued to selling physicians or their advisors as part of
the consideration in a Permitted Acquisition or issued to
Directors, Officers and other employees of the Borrowers and
other Accredited Investors as defined by Rule 501 under the
Securities Act of 1933, as amended, no options, warrants,
conversion rights, preemptive rights or other statutory or
contractual rights to purchase shares of capital stock or
other securities of any Borrower, other than the Company, now
exist, nor has any Borrower, other than the Company,
authorized any such right, nor is any Borrower, other than the
Company, obligated in any other manner to issue shares of its
capital stock or other securities."
3. NO DEFAULT. In order to induce the Lenders to enter into this Amendment and
to continue to extend credit to the Borrowers under the Credit Agreement as
amended hereby, each of the Borrowers represents and warrants that, after giving
effect to this Amendment, no Default under the Credit Agreement as amended
hereby exists.
4. MISCELLANEOUS. Except to the extent specifically amended hereby, the
provisions of the Credit Agreement shall remain unmodified, and the Credit
Agreement as amended hereby is confirmed as being in full force and effect. This
Amendment may be executed in any number of counterparts which together shall
constitute one instrument, shall be governed by and construed in accordance with
the laws of The Commonwealth of Massachusetts (other than conflict of laws
rules), and shall bind and inure to the benefit of the parties hereto and their
respective successors and assigns, including as such successors and assigns all
holders of Credit Obligations.
IN WITNESS WHEREOF, the parties have caused this Amendment to be
executed and delivered by their duly authorized officers as of the date first
above written.
PEDIATRIX MEDICAL GROUP, INC.
By: /s/ Lawrence M. Mullen
------------------------
Lawrence M. Mullen, Vice President and
Chief Financial Officer
PEDIATRIX MEDICAL GROUP OF
FLORIDA, INC.
By: /s/ Lawrence M. Mullen
-----------------------
Lawrence M. Mullen, Treasurer
PEDIATRIX MEDICAL GROUP, P.C. (WV)
By: /s/ Lawrence M. Mullen
-----------------------
Lawrence M. Mullen, Treasurer
PEDIATRIX MEDICAL GROUP, P.C. (VA)
By: /s/ Lawrence M. Mullen
-----------------------
Lawrence M. Mullen, Treasurer
PEDIATRIX MEDICAL GROUP, S.P. (PR)
By: /s/ Lawrence M. Mullen
-----------------------
Lawrence M. Mullen, Attorney-in-Fact
PEDIATRIX MEDICAL GROUP, P.A. (NJ)
By: /s/ Lawrence M. Mullen
-----------------------
Lawrence M. Mullen, Treasurer
PEDIATRIX MEDICAL GROUP OF
KANSAS, P.A.
By: /s/ Lawrence M. Mullen
-----------------------
Lawrence M. Mullen, Attorney-in-Fact
PEDIATRIX MEDICAL GROUP
NEONATOLOGY
AND PEDIATRIC INTENSIVE CARE
SPECIALISTS OF NEW YORK, P.C.
By: /s/ Lawrence M. Mullen
-----------------------
Lawrence M. Mullen, Attorney-in-Fact
PEDIATRIX MEDICAL GROUP OF
CALIFORNIA, P.C.
By: /s/ Lawrence M. Mullen
-----------------------
Lawrence M. Mullen, Attorney-in-Fact
PEDIATRIX MEDICAL GROUP OF
ILLINOIS, P.C.
By: /s/ Lawrence M. Mullen
-----------------------
Lawrence M. Mullen, Attorney-in-Fact
PEDIATRIX MEDICAL GROUP OF
MICHIGAN, P.C.
By: /s/ Lawrence M. Mullen
-----------------------
Lawrence M. Mullen, Treasurer
PEDIATRIX MEDICAL GROUP OF
PENNSYLVANIA, P.C.
By: /s/ Lawrence M. Mullen
-----------------------
Lawrence M. Mullen, Attorney-in-Fact
PEDIATRIX MEDICAL GROUP OF
TEXAS, P.A.
By: /s/ Lawrence M. Mullen
-----------------------
Lawrence M. Mullen, Attorney-in-Fact
PEDIATRIX MEDICAL GROUP OF
OHIO, CORP.
By: /s/ Lawrence M. Mullen
-----------------------
Lawrence M. Mullen, Treasurer
NEONATAL SPECIALISTS, LTD. (AZ)
By: /s/ Lawrence M. Mullen
-----------------------
Lawrence M. Mullen, Treasurer
PEDIATRIX MEDICAL GROUP OF
COLORADO, P.C.
By: /s/ Lawrence M. Mullen
-----------------------
Lawrence M. Mullen, Attorney-in-Fact
ST. JOSEPH NEONATOLOGY
CONSULTANTS, P.A.
By: /s/ Lawrence M. Mullen
-----------------------
Lawrence M. Mullen, Attorney-in-Fact
PERNOLL MEDICAL GROUP OF
NEVADA, LTD. D/B/A PEDIATRIX
MEDICAL GROUP OF NEVADA
By: /s/ Lawrence M. Mullen
-----------------------
Lawrence M. Mullen, Attorney-in-Fact
PEDIATRIX MEDICAL GROUP OF
SOUTH CAROLINA, P.A.
By: /s/ Lawrence M. Mullen
-----------------------
Lawrence M. Mullen, Treasurer
FLORIDA REGIONAL NEONATAL
ASSOCIATES, P.A.
By: /s/ Lawrence M. Mullen
-----------------------
Lawrence M. Mullen, Treasurer
PEDIATRIX MEDICAL GROUP, INC.
(UT)
By: /s/ Lawrence M. Mullen
-----------------------
Lawrence M. Mullen, Treasurer
PEDIATRIX MEDICAL GROUP OF
NEW MEXICO, P.C.
By: /s/ Lawrence M. Mullen
-----------------------
Lawrence M. Mullen, Treasurer
PEDIATRIX MEDICAL GROUP OF
WASHINGTON, INC., P.C.
By: /s/ Lawrence M. Mullen
-----------------------
Lawrence M. Mullen, Treasurer
PEDIATRIX MEDICAL GROUP OF
INDIANA, P.C.
By: /s/ Lawrence M. Mullen
-----------------------
Lawrence M. Mullen, Attorney-in-Fact
FORT WORTH NEONATAL
ASSOCIATES, P.A.
By: /s/ Lawrence M. Mullen
-----------------------
Lawrence M. Mullen, Attorney-in-Fact
PMG ACQUISITION CORP.
By: /s/ Lawrence M. Mullen
-----------------------
Lawrence M. Mullen, Treasurer
PEDIATRIX MEDICAL GROUP OF
PUERTO RICO, P.S.C.
By: /s/ Lawrence M. Mullen
-----------------------
Lawrence M. Mullen, Attorney-in-Fact
OBSTETRIX MEDICAL GROUP, INC.
By: /s/ Lawrence M. Mullen
-----------------------
Lawrence M. Mullen, Treasurer
OBSTETRIX MEDICAL GROUP OF
FLORIDA, INC.
By: /s/ Lawrence M. Mullen
-----------------------
Lawrence M. Mullen, Treasurer
PALM BEACH NEO ACQUISITIONS, INC.
By: /s/ Lawrence M. Mullen
-----------------------
Lawrence M. Mullen, President
MARCIA J. PERNOLL, M.D. PROF. CORP. (NV)
By: /s/ Lawrence M. Mullen
-----------------------
Lawrence M. Mullen, Attorney-in-Fact
OBSTETRIX MEDICAL GROUP OF COLORADO, P.C.
By: /s/ Lawrence M. Mullen
------------------------
Lawrence M. Mullen, Attorney-in-Fact
PEDIATRIX MEDICAL GROUP OF ARKANSAS, P.A.
By: /s/ Lawrence M. Mullen
-----------------------
Lawrence M. Mullen, Attorney-in-Fact
OBSTETRIX MEDICAL GROUP OF ARIZONA, P.C.
By: /s/ Lawrence M. Mullen
-----------------------
Lawrence M. Mullen, Attorney-in-Fact
OBSTETRIX MEDICAL GROUP OF KANSAS AND MISSOURI, P.A.
By: /s/ Lawrence M. Mullen
-----------------------
Lawrence M. Mullen, Attorney-in-Fact
OBSTETRIX MEDICAL GROUP OF TEXAS, P.A.
By: /s/ Lawrence M. Mullen
-----------------------
Lawrence M. Mullen, Attorney-in-Fact
PEDIATRIX MEDICAL GROUP OF GEORGIA, P.C.
By: /s/ Lawrence M. Mullen
-----------------------
Lawrence M. Mullen, Attorney-in-Fact
BANKBOSTON, N.A.
(formerly known as The First National Bank
of Boston)
By: /s/ Jeffrey G. Millman
-----------------------
Jeffrey G. Millman, Vice President
BankBoston, N.A.
New England Corporate Banking
100 Federal Street
Boston, Massachusetts 02110
Telecopy: (617) 434-1279
Telex: 940581
SUNTRUST BANK/CENTRAL FLORIDA,
NATIONAL ASSOCIATION
By: /s/ Janet P. Sammons
---------------------
Janet P. Sammons, Vice President
SunTrust Bank/Central Florida, National
Association
Health Care Banking Group
Mail Code: 0-1101
200 S. Orange Avenue
Orlando, Florida 32801
Telecopy (407) 237-5489
PEDIATRIX EXECUTIVE NON-QUALIFIED
DEFERRED COMPENSATION PLAN
-------------------------------------------------------
THIS PEDIATRIX EXECUTIVE NON-QUALIFIED DEFERRED COMPENSATION PLAN (the
"Plan") made and entered into this 13 day of October, 1997, by PEDIATRIX
MEDICAL GROUP, INC., a corporation duly organized and existing under the laws of
the State of Florida (the "Company").
RECITALS:
---------
The Company desires to permit officers and other executives of the
Company and its Affiliates to defer a portion of their compensation from the
Company and its Affiliates, subject to certain conditions and pursuant to the
terms and provisions specified in this Plan. Additionally, the Company desires
to provide a plan for the Company and its Affiliates to make matching and other
contributions on a discretionary basis.
NOW, THEREFORE, in consideration of the premises and mutual covenants
set forth herein, the Company hereby establishes the Plan pursuant to the
following terms and provisions.
ARTICLE 1 1
DEFINITIONS
1.1 "Accounting Date" means the last day of each calendar month and
such other date or dates as the Committee may designate from time to time as an
Accounting Date.
1.2 "Accounting Period" means each period beginning on the day
following an Accounting Date and ending on the following Accounting Date.
1.3 "Affiliate" means the following companies related to the Company
through long-term management contracts: Pediatrix Medical Group of Arizona,
California, Colorado, Florida, Illinois, Indiana, Kansas, Michigan, Nevada, New
Jersey, New Mexico, New York, Ohio, Pennsylvania, Puerto Rico, South Carolina,
Texas, Utah, Virginia, Washington and West Virginia and any future majority
owned subsidiary of the Company or any business entity, partnership or other
business entity related to the Company through a long-term management contract.
1.4 "Beneficiary" means the person or persons designated by a
Participant, upon such forms as shall be provided by the Committee, to receive
payments of the vested portion of the Participant's Accounts after the
Participant's death. If the Participant shall fail to designate a Beneficiary,
or if for any reason such designation shall be ineffective, or if such
Beneficiary shall predecease the Participant or die simultaneously with him,
then the Beneficiary shall be, in the following order of preference:
(a) the Participant's surviving spouse, or
(b) the Participant's estate.
1.5 "Change of Control" shall mean approval by the shareholders of
the Company of (a) a reorganization, merger, consolidation or other form of
corporate transaction or series of transactions, in each case, with respect to
which persons who were the shareholders of the Company immediately prior to such
reorganization, merger or consolidation or other transaction do not, immediately
thereafter, own more than 50% of the combined voting power entitled to vote
generally in the election of directors of the reorganized, merged or
consolidated company's then outstanding voting securities, (b) a liquidation or
dissolution of the Company or (c) the sale of all or substantially all of the
assets of the Company (unless such reorganization, merger, consolidation or
other corporate transaction, liquidation, dissolution or sale is subsequently
abandoned).
1.6 "Code" shall mean the Internal Revenue Code of 1986, as amended,
and successor tax laws.
1.7 "Committee" shall mean the persons designated by the Company as
the Administrative Committee for the Plan, as it may from time to time be
constituted, pursuant to Section 7.1.
1.8 "Company" shall mean Pediatrix Medical Group, Inc., a Florida
corporation, its successors and assigns.
1.9 "Deferral Agreement" shall mean the agreement entered into by an
Eligible Person in accordance with Section 3.1 hereof pursuant to which the
Eligible Person shall elect the amount of his Tax-Deferred Contributions for the
Plan Year.
1.10 "Disability" shall mean a disability as that term is defined in
the Long Term Disability Plan of the Participating Company that employs the
Participant, if any, or if there is no Long Term Disability Plan, disability
shall mean a physical or mental condition that renders, or is expected to
render, the Participant permanently and totally unable to perform his usual
duties or any comparable duties for the Participating Company. The determination
of the existence of a Disability shall be made by the Committee and shall be
final and binding upon the Participant and all other parties. The Committee may
require the submission of such medical evidence as it may deem necessary in
order to arrive at its determination.
1.11 "Effective Date of Plan" shall mean January 1, 1998.
1.12 "Eligible Compensation" shall mean the base salary, bonuses and
commissions paid by the Participating Company to the Eligible Person for the
Plan Year.
1.13 "Eligible Person" shall mean officers and executives of the
Company having the following titles and any other person designated by the
Company as being eligible to participate in the Plan, and who satisfy such other
conditions as the Company may from time to time establish for eligibility to
participate in this Plan:
Chairman of the Board
Chief Executive Officer
Chief Financial Officer
Chief Operating Officer
Chief Information Officer
General Counsel
Executive Vice President
Senior Vice President
Vice President of Business Development
Vice President of International
Vice President of Medical Affairs
Vice President of Practice Integration
Vice President of Special Projects
Regional Medical Officer
1.14 "Employer Contribution Account" means the account maintained
under the Plan for a Participant that is credited with Matching Contributions
and Other Contributions.
1.15 "Investment Funds" means those investment options that shall
from time to time be made available as investment options under the Plan, as
determined by the Committee.
1.16 "Leave of Absence" shall mean any absence authorized by the
Participating Company that employs the Participant under its standard personnel
practices, provided that all persons under similar circumstances shall be
treated alike in the granting of such authorized Leave of Absence.
1.17 "Matching Contributions" means the matching contributions
credited to the Participant's Account in accordance with Section 3.2 of the
Plan.
1.18 "Normal Retirement Age" shall mean the date on which the
Participant reaches the age of sixty-five.
1.19 "Other Employer Contributions" shall mean any contributions
credited to the Participant's Account in accordance with Section 3.3 of the
Plan.
1.20 "Participant" shall mean an Eligible Person who becomes a
Participant pursuant to Section 2.1 hereof.
1.21 "Participant's Account" means the total amount credited to the
account maintained in the Plan in accordance with the provisions of the Plan for
each Participant as of any Accounting Date, and which consists of his
Tax-Deferred Contributions Account and his Employer Contributions Account.
1.22 "Participating Company" means the Company and each Affiliate
that adopts the Plan with the consent of the Company.
1.23 "Plan" shall mean the Pediatrix Executive Non-Qualified
Deferred Compensation Plan as herein set forth and as it may be amended from
time to time.
1.24 "Plan Year" shall mean each calendar year that begins on or after
January 1, 1998.
1.25 "Tax-Deferred Contributions" means the compensation reduction
contributions credited to the Participant's Account under Section 3.1 of the
Plan.
1.26 "Tax-Deferred Contributions Account" means the account
maintained by the Company under the Plan for a Participant that is credited with
the Participant's Tax-Deferred Contributions.
1.27 "Trust" means the Physicians, Medical Directors and Executives
Deferred Compensation Plan Trust for Pediatrix Medical Group, Inc. between each
Participating Company and the Trustee.
1.28 "Trustee" shall mean the persons or entity that shall from time
to time be serving as the Trustee of the Trust.
ARTICLE 2
ELIGIBILITY
2.1 Determining Eligibility. An Eligible Person shall become a
Participant in the Plan on (i) January 1, 1998, in the case of individuals who
are Eligible Persons on December 31, 1997, and (ii) in the case of any other
Eligible Person, on the January 1, April 1, July 1 or October 1 coincident with
or immediately following that date on which he becomes an Eligible Person. As a
condition to an Eligible Person's becoming a Participant, the Eligible Person
shall, at the request of the Committee, complete such applications and other
forms, and submit to such physical examination, as may be required in order for
the Company to purchase one or more life insurance policies on the Eligible
Person's life, in such amounts as the Committee shall determine.
ARTICLE 3
CONTRIBUTIONS
3.1 Tax-Deferred Contributions. Each Participant, so long as he
remains a Participant, may elect (pursuant to a Deferral Agreement furnished by
the Committee prior to the beginning of the Plan Year and in accordance with
Committee rules) to reduce and defer receipt pursuant to this Plan of (a) an
amount not to exceed twenty-five percent (25%) (in whole percentages) of his
base salary earned during the Plan Year, (b) an amount up to one hundred percent
(100%) (in whole percentages) of any bonus earned during the Plan Year, and/or
(c) an amount up to one hundred percent (100%) (in whole percentages) or any
commissions earned during the Plan Year. Deferral Agreements are effective on a
Plan Year basis, and must be filed before the beginning of the Plan Year to
which they relate. Deferral Agreements may not be amended or revoked after the
beginning of the Plan Year. Each Participating Company shall withhold, by
payroll deduction, the Eligible Compensation deferred pursuant to this Section
3.1 from the current Eligible Compensation payments of a Participant and credit
such withheld amounts to a Participant's Tax-Deferred Contributions Account
under the Plan. Special rules for New Participants: An Eligible Person who
becomes a Participant during a Plan Year may file a Participant Deferral
Agreement within thirty (30) days after becoming a Participant. The Deferral
Agreement shall apply to the Eligible Compensation received after the individual
becomes a Participant and may not be amended or revoked during the Plan Year for
which it is made.
3.2 Matching Contributions. For each Plan Year, each Participating
Company shall credit to the Employer Contribution Account of each Participant
that is an employee of the Participating Company an amount equal to such
percentage, if any, of the Participant's Tax-Deferred Contributions as the
Participating Company, in its discretion, shall from time to time determine.
3.3 Other Employer Contributions. For each Plan Year, each
Participating Company shall credit to any Employer Contribution Account of a
Participant employed by the Participating Company such contributions, if any, as
the Participating Company shall determine for such Participant based upon such
criteria as the Participating Company, in its discretion, shall from time to
time determine.
ARTICLE 4
VESTING
4.1 Tax-Deferred Contributions Account. A Participant's interest in
his Tax-Deferred Contributions Account shall be fully vested and nonforfeitable
at all times.
4.2 Employer Contributions Account. A Participant shall be fully
vested in his Employer Contributions Account on the first to occur of:
(a) completion of three (3) continuous years of employment with
the Company and/or an Affiliate (including any Leave of Absence), commencing at
any time on or after the date on which the Participant first becomes a
Participant;
(b) the death of the Participant while employed by the Company or
an Affiliate; or
(c) the date on which the Participant becomes Disabled while
employed by the Company or an Affiliate.
4.3 Forfeiture. A Participant shall forfeit the full amount of his
Employer Contributions Account in the event that his employment with the Company
or any Affiliate is terminated prior to the date on which his Employer
Contributions Account is fully vested pursuant to Section 4.2.
ARTICLE 5
INVESTMENT OF PARTICIPANT'S ACCOUNT AND TRUST
5.1 Investment. Amounts credited to a Participant's Account shall be
contributed by the Company to the Trust as soon as practicable after they are so
credited. The value of a Participant's Account shall be measured as if amounts
credited to such Account were actually invested in the Investment Funds selected
by the Participant in accordance with the Plan, and shall be credited with gains
and losses allocable thereto at such times and in such manner as shall be
determined by the Committee. Each Eligible Employee upon becoming a Participant
shall elect on the Participant Election and Enrollment Form the portion of the
Participant's Account, in whole percentages, that are to be treated as if
invested in each of the Investment Funds. A Participant may, as of the first day
of each calendar quarter and in such manner as shall be permitted by the
Committee, change such election as to the investments upon which the value of
his Participant's Account is to be measured. The Company may direct the Trustees
that the assets of each Trust be invested in any one, or combination, of the
Investment Funds, or in any other investments determined by the Company,
notwithstanding the Participant's election as to the manner in which the value
of his Account is to be measured. In the event that the Investment Funds are
those that are part of a life insurance policy, then the value of the
Participant's Account shall be measured as if it were invested in the Investment
Funds selected by the Participant within a life insurance policy which could be
acquired by the Company or Trust in accordance with the Plan, and shall be
reduced by all cost of insurance and other policy costs, expenses and other
charges (including any potential charges) that are or would be incurred if such
Policy were maintained. In no event, however, shall the Company be required to
purchase or continue to maintain any such life insurance policies, or to invest
any amounts within the life insurance policy in accordance with the
Participant's election with regard to the manner in which the value of his
Account is to be measured.
ARTICLE 6
DISTRIBUTIONS
6.1 Timing of Distributions.
(a) Participant's Account. The vested portion of the
Participant's Account, less any applicable tax withholding, shall be distributed
to the Participant commencing upon the Participant's termination of employment
with the Company and its Affiliates for any reason, including the Participant's
death or Disability. The distribution shall commence as soon as administratively
practicable after the first day of the calendar month immediately following the
date of the Participant's termination of employment with the Company and its
Affiliates. The Company may, in its discretion, defer the distribution until the
Participant's Normal Retirement Age. If the Company defers the Participant's
distribution, the Participant may continue to direct the manner in which his
Participant's Account is deemed to be invested until actual distribution.
(b) Acceleration of Distributions. Distribution shall be
accelerated upon the following occurrences:
(i) Hardship Distributions. Upon the written request
of a Participant and in the event the Committee determines that an
"unforeseeable emergency" has occurred with respect to a Participant, the
Participant may withdraw the lesser of (1) the amount necessary to meet the
emergency or (2) the vested portion of the Participant's Account. For this
purpose, an "unforeseeable emergency" shall mean an unanticipated emergency,
such as a sudden and unexpected illness or accident of the Participant or a
dependent of the Participant or loss of the Participant's property due to
casualty, that is caused by an event beyond the control of the Participant and
that would result in severe financial hardship if the withdrawal were not
permitted. The need to pay a Participant's child's tuition to college and the
desire to purchase a home shall not be considered unforeseeable emergencies; or
(ii) Change of Control. In the event of a Change of
Control as defined in Section 1.5 hereof, the full amount of the Participant's
Account shall be distributed to the Participant as soon as administratively
practicable following the Change of Control, unless the Board of Directors of
the Company as constituted immediately prior to the Change of Control shall
otherwise provide.
6.2 Form of Distribution. The distribution to the Participant shall
be made in cash either (a) in a lump sum distribution or (b) in up to twenty
(20) consecutive quarterly installments, as elected by the Participant. Each
quarterly installment shall be equal to the remaining value of the Participant's
Account being distributed multiplied by a fraction, the numerator of which is 1
and the denominator of which is the number of quarterly installments remaining
to be paid. A Participant may elect, on a form provided by the Committee, the
form in which his Participant's Account is to be distributed under this Section
6.2; provided, however, that no such election, or change in any election, shall
be given effect unless it is made at least one year prior to the date on which
distribution of the Participant's Account commences. In the event that a
Participant fails to make an election, then distribution shall be made in the
form of a lump sum.
6.3 Distribution to Beneficiary. If a Participant dies before
distribution of the entire vested portion of the Participant's Accounts has been
made to him, the remaining vested portion of his Participant's Account, less
applicable withholding taxes, shall be distributed to the Participant's
Beneficiaries in a lump sum distribution in cash.
ARTICLE 7
ADMINISTRATION
7.1 Administrative Committee. The Company shall appoint a Committee
for the administration of the Plan consisting of one or more persons. Any
Committee member may, but need not, be an officer or employee of any
Participating Company and each shall serve until his successor shall be
appointed in like manner. Any member of the Committee may resign by delivering
his written resignation to the Company. The Company may remove any member of the
Committee at any time.
7.2 Powers and Duties. The Committee generally shall be responsible
for the management, operation, interpretation and administration of the Plan.
The Committee shall:
(a) Establish procedures for allocation of responsibilities of
the Plan which are not allocated herein;
(b) Determine the names of those officers and other executives
who are eligible to participate and such other matters as may be necessary to
enable payment under the Plan;
(c) Construe all terms, provisions, conditions and limitations of
the Plan and make all factual determinations relating to the Plan;
(d) Correct any defect, supply any omission or reconcile any
inconsistency that may appear in the Plan and make all factual determinations
relating to the Plan;
(e) Determine the amount, manner and time of payment of any
benefits hereunder and prescribe procedures to be followed by Participants to
obtain benefits; and
(f) Perform such other functions and take such other actions as
may be required by the Plan or as may be necessary or advisable to accomplish
the purposes of the Plan.
The Company shall furnish the Committee with all data and information available
which the Committee may reasonably require in order to perform its functions
hereunder. The Committee may rely without question upon any such data or
information furnished by the Company. Any interpretation or other decision made
by the Committee shall be final, binding and conclusive upon all persons in the
absence of clear and convincing evidence that the Committee acted arbitrarily
and capriciously.
7.3 Agents. The Committee may appoint a Secretary who may, but need
not, be a member of the Committee, and may employ such agents for clerical and
other services, and such counsel, accountants and other professional advisors as
may be required for the purpose of administering the Plan. The Committee may
rely on all tables, valuations, reports, certificates and opinions furnished by
its agents.
7.4 Procedures. A majority of the Committee members shall constitute
a quorum for the transaction of business. No action shall be taken except upon a
majority vote of the Committee. An individual shall not vote or decide upon any
matter relating solely to himself or vote in any case in which his individual
right or claim to any benefit under the Plan is particularly involved. In any
case in which a Committee member is so disqualified to act, and the remaining
members cannot agree on an issue, the Company shall appoint a temporary
substitute member to exercise all of the powers of the disqualified member
concerning the matter in which he is disqualified.
7.5 Claims Procedure. In the event that any Participant or
Beneficiary claims to be entitled to benefits under the Plan and the Committee
determines that such claim should be denied in whole or in part, the Committee
shall, in writing, notify such claimant within ninety (90) days of receipt of
such claim that his claim has been denied, setting forth the specific reasons
for such denial. Such notification shall be written in a manner reasonably
expected to be understood by such Participant or Beneficiary and shall set forth
the pertinent sections of the Plan relied on, and where appropriate, an
explanation of how the claimant can obtain review of such denial.
Within sixty (60) days after the mailing or delivery by the Committee
of such notice, such claimant may request, by mailing or delivery of written
notice to the Committee, a review and/or hearing by the Committee of the
decision denying the claim. If the claimant fails to request such a review
and/or hearing within such sixty (60) day period, it shall be conclusively
determined for all purposes of this Plan that the denial of such claim by the
Committee is correct. If such claimant requests a hearing within such sixty (60)
day period, the Committee shall designate a time (which time shall not be less
than seven (7) nor more than sixty (60) days from the date of such claimant's
notice to the Committee) and a place for such hearing, and shall promptly notify
such claimant of such time and place. A claimant or his authorized
representative shall be entitled to inspect all pertinent Plan documents and to
submit issues and comments in writing. If only a review is requested, the
claimant shall have sixty (60) days after filing a request for review to submit
additional written material in support of the claim. After such review and/or
hearing, the Committee shall promptly determine whether such denial of the claim
was correct and shall notify such claimant in writing of its determination with
sixty (60) days after such review and/or hearing or after receipt of any
additional information submitted.
7.6 Indemnification. The Participating Companies shall indemnify each
Committee member against any liability or loss sustained by reason of any act or
failure to act made in good faith, including, but not limited to, those in
reliance on certificates, reports, tables, opinions or other communications from
any company or agents chosen by the Committee in good faith. Such
indemnification shall include attorneys' fees and other costs and expenses
reasonably incurred in defense of any action brought by reason of any such act
or failure to act.
7.7 Participants Bound. Any action with respect to the Plan taken by
the Committee, any Participating Company or the Trustees or any action
authorized by or taken at the direction of the Committee, any Participating
Company or the Trustees shall be conclusive upon all Participants and
beneficiaries entitled to benefits under the Plan.
7.8 Receipts and Release. Any payment to any Participant or
beneficiary in accordance with the provisions of the Plan shall, to the extent
thereof, be in full satisfaction of all claims against the Participating
Companies, the Committee and the Trustee under the Plan, and the Committee may
require such Participant or beneficiary, as a condition precedent to such
payment, to execute a receipt and release to such effect. If any Participant or
beneficiary is determined by the Committee to be incompetent by reason of
physical or mental disability (including minority) to give a valid receipt and
release, the Committee may cause the payment or payments becoming due to such
person to be made to another person for his or her benefit without
responsibility on the part of the Committee, the Participating Companies or the
Trustee to follow the application of such funds.
ARTICLE 8
MISCELLANEOUS
8.1 Unfunded Plan. The obligations of the Participating Companies
under this Plan shall be paid from the general assets of the Participating
Companies and not from any particular fund, with each Participating Company
being solely responsible for payment of the benefits of its employees and their
beneficiaries. It is intended that this Plan shall constitute an "unfunded" plan
for a select group of management or highly compensated employees under the
Employee Retirement Income Security Act of 1974, as amended. If a Participating
Company purchases any life insurance policies, or makes any other investments,
either directly or through the Trust, such policies (and any amounts invested by
the Participating Company therein) and any other investments of the
Participating Company or the Trust shall be subject to the claims of the
Participating Company's creditors. Nothing contained in this Plan shall be
interpreted to grant to any Participant or Beneficiary, any right, title or
interest in any property of the Company or the Trust.
8.2 Successor Plan. In the event that a Participant ceases to be an
Eligible Person, but becomes an Eligible Person under any non-qualified deferred
compensation plan maintained by a Participating Company (the "Successor Plan"),
then the Participant's Accounts under this Plan shall, in the discretion of the
Committee, cease to be governed by this Plan and instead shall be governed by
the provisions of the Successor Plan.
8.3 Impact on Other Participant Benefits. This Plan shall not be
construed to impact or cause the denial of any benefits to which any Participant
may be entitled under any other welfare or benefit plan of any Participating
Company.
8.4 Other Plans. Payments made to Participants under this Plan shall
not be includable as salary or compensation for purposes of determining the
amount of employee benefits under any other retirement, pension, profit-sharing
or welfare benefit plans of the Participating Companies.
8.5 Tax Withholding. The Committee and/or the Trustees shall withhold
from any contribution to, amounts accumulated under, or distribution from, the
Plan or Trust such amounts as the Committee or the Trustees shall be determined
to be appropriate for Federal or State local taxes attributable thereto.
8.6 Governing Law. To the extent not preempted by the laws of the
United States, the construction, validity and administration of the Plan shall
be governed by the laws of the state Florida without reference to the principles
of conflicts of law therein.
8.7 No Assignment. The right to receive payment of any benefits under
the Plan shall not be transferred, assigned or pledged.
8.8 Severability. If any provision of this Plan is found, held or
deemed to be void, unlawful or unenforceable under any applicable statute or
other controlling law, the remainder of the Plan shall continue in full force
and effect.
8.9 Headings and Subheadings. Headings and subheadings in this Plan
are for reference only. In the event of a conflict between a heading or
subheading and the content of an article or paragraph, the content shall
control.
8.10 Gender. The masculine, as used herein, shall be deemed to
include the feminine and the singular to include plural, except where the
context requires a different construction.
8.11 Amendment and Termination. This Plan may be amended or
terminated in any respect at any time by the Company; provided, however, that no
amendment or termination of the Plan shall be effective to reduce any benefits
that accrue before the adoption of such amendment or termination. In the event
that the Plan is terminated, then distributions shall be made to all
Participants and Beneficiaries of the vested portion of their Participant's
Account in a single lump sum payment as soon as practicable following such
termination.
8.12 No Employment Contract. This Plan does not constitute a
contract of employment or impose on any Participant or any Participating Company
any obligations to retain the Participant as an employee, to change the status
of the Participant's employment, or to change the Participating Company's
policies regarding termination of employment.
8.13 Right of Offset. The Company shall have the right to offset
against any benefits payable to any Participant or the Beneficiary if any
Participant under the Plan, any amounts payable by the Participant to the
Company.
IN WITNESS WHEREOF, each Participating Company has caused the Plan to
be executed the day and year first above written.
PEDIATRIX MEDICAL GROUP, INC.
By: /s/ Lawrence M. Mullen
----------------------
Lawrence M. Mullen, Vice President and
Chief Financial Officer
PEDIATRIX MEDICAL GROUP OF
FLORIDA, INC.
By: /s/ Lawrence M. Mullen
-----------------------
Lawrence M. Mullen, Treasurer
PEDIATRIX MEDICAL GROUP, P.C. (WV)
By: /s/ Lawrence M. Mullen
-----------------------
Lawrence M. Mullen, Treasurer
PEDIATRIX MEDICAL GROUP, P.C. (VA)
By: /s/ Lawrence M. Mullen
-----------------------
Lawrence M. Mullen, Treasurer
PEDIATRIX MEDICAL GROUP, S.P. (PR)
By: /s/ Carlos Perez, M.D.
-----------------------
Carlos Perez, M.D. Managing Partner
PEDIATRIX MEDICAL GROUP, P.A. (NJ)
By: /s/ Kerry Weiss, M.D.
----------------------
Kerry Weiss, M.D., President
PEDIATRIX MEDICAL GROUP OF
KANSAS, P.A.
By: /s/ Eduardo Otero, M.D.
------------------------
Eduardo Otero, M.D., President
PEDIATRIX MEDICAL GROUP
NEONATOLOGY
AND PEDIATRIC INTENSIVE CARE
SPECIALISTS OF NEW YORK, P.C.
By: /s/ Willard Helmuth, M.D.
--------------------------
Willard Helmuth, M.D., President
PEDIATRIX MEDICAL GROUP OF
CALIFORNIA, P.C.
By: /s/ Carlos Perez, M.D.
-----------------------
Carlos Perez, M.D., President
PEDIATRIX MEDICAL GROUP OF
ILLINOIS, P.C.
By: /s/ Brian Udell, M.D.
----------------------
Brian Udell, M.D., President
PEDIATRIX MEDICAL GROUP OF
MICHIGAN, P.C.
By: /s/ Brian Udell, M.D.
----------------------
Brian Udell, M.D., President
PEDIATRIX MEDICAL GROUP OF
PENNSYLVANIA, P.C.
By: /s/ Brian Udell, M.D.
----------------------
Brian Udell, M.D., President
PEDIATRIX MEDICAL GROUP OF
TEXAS, P.A.
By: /s/ Stephen Haskins, M.D.
--------------------------
Stephen Haskins, M.D., President
PEDIATRIX MEDICAL GROUP OF
OHIO, CORP.
By: /s/ Brian Udell, M.D.
----------------------
Brian Udell, M.D., President
NEONATAL SPECIALISTS, LTD. (AZ)
By: /s/ Brian Udell, M.D.
----------------------
Brian Udell, M.D., President
PEDIATRIX MEDICAL GROUP OF
COLORADO, P.C.
By: /s/ Eric Kurzweil, M.D.
------------------------
Eric Kurzweil, M.D., President
ST. JOSEPH NEONATOLOGY
CONSULTANTS, P.A.
By: /s/ Stephen Haskins, M.D.
--------------------------
Stephen Haskins, M.D., President
PERNOLL MEDICAL GROUP OF
NEVADA, LTD. D/B/A PEDIATRIX
MEDICAL GROUP OF NEVADA
By: /s/ Marcia Pernoll, M.D.
-------------------------
Marcia Pernoll, M.D., President
PEDIATRIX MEDICAL GROUP OF
SOUTH CAROLINA, P.A. (n/k/a PMGSC, P.A.)
By: /s/ Brian Udell, M.D.
----------------------
Brian Udell, M.D., President
PIEDMONT PERINATAL, P.A.
(n/k/a PEDIATRIX MEDICAL GROUP OF SOUTH
CAROLINA, P.A.)
By: /s/ Brian Udell, M.D.
----------------------
Brian Udell, M.D., President
FLORIDA REGIONAL NEONATAL
ASSOCIATES, P.A.
By: /s/ Lawrence M. Mullen
-----------------------
Lawrence M. Mullen, Treasurer
PEDIATRIX MEDICAL GROUP, INC.
(Utah)
By: /s/ Nick E. Harper, M.D.
-------------------------
Nick E. Harper, M.D., President
PEDIATRIX MEDICAL GROUP OF
NEW MEXICO, P.C.
By: /s/ Lawrence M. Mullen
--------------------------
Lawrence M. Mullen, Treasurer
PEDIATRIX MEDICAL GROUP OF
WASHINGTON, INC., P.C.
By: /s/ Lawrence M. Mullen
-----------------------
Lawrence M. Mullen, Treasurer
PEDIATRIX MEDICAL GROUP OF
INDIANA, P.C.
By: /s/ Brian Udell, M.D.
----------------------
Brian Udell, M.D., President
STATEMENT RE: COMPUTATION OF PER SHARE EARNINGS
Three Months Ended Six Months Ended
June 30, June 30,
---------------------------------- -----------------------------------
1998 1997 1998 1997
-------------- --------------- --------------- ---------------
(in thousands, except for per share data)
Basic:
Net income applicable to common
stock $ 7,107 $ 4,768 $ 13,226 $ 9,076
============== =============== =============== ===============
Weighted average number of
common shares outstanding 15,226 15,001 15,192 14,944
============== =============== =============== ===============
Basic net income per share $ .47 $ .32 $ .87 $ .61
============== =============== =============== ===============
Diluted:
Net income applicable to common
stock $ 7,107 $ 4,768 $ 13,226 $ 9,076
============== =============== =============== ===============
Weighted average number of
common shares outstanding 15,226 15,001 15,192 14,944
Weighted average number of
dilutive common stock equivalents 674 677 679 667
-------------- --------------- --------------- ---------------
Weighted average number of
common and common equivalent
shares outstanding 15,900 15,678 15,871 15,611
============== =============== =============== ===============
Diluted net income per share $ .45 $ .30 $ .83 $ .58
============== =============== =============== ===============
5
1000
6-MOS
DEC-31-1998
JAN-1-1998
JUN-30-1998
1753
0
46,219
0
0
49,538
10,644
0
230,806
33,638
12,450
0
0
152
179,466
230,806
0
83,952
0
62,045
(491)
0
351
22,047
8,821
13,226
0
0
0
13,226
0.87
0.83
AMOUNTS FOR RECEIVABLES AND PROPERTY, PLANT AND
EQUIPMENT ARE NET OF ANY ALLOWWANCES AND ACCUMULATED
DEPRECIATION.
